Perrigo $PRGO to Sell Tysabri Royalty Stream to Royalty Pharma for Up to $2.85B BIO-PHARMA, INTELLECTUAL PROPERTY, IRELAND, ISRAEL, LIFE SCIENCES, M&A, NEW YORK CITY, NYSE, PATENTS, PHARMACEUTICALS, TEL AVIV STOCK EXCHANGE